政策动向 2026年医保目录调整新增预申报允许商保创新药申报医保目录 国家医保局介绍2026年国家医保药品目录及商业健康保险创新药品目录调整工作安排,包括首次允许纳入2025年商保创新药目录的药品申报国家医保目录,新增“预申报”环节等。 国家医保局医药服务管理司司长黄心宇介绍,这是该局成立以来连续第9年动态调整医保目录,工作程序总体保持稳定,分为准备、申报、评审、谈判、公布结果5个阶段。预计...
Source Link政策动向 2026年医保目录调整新增预申报允许商保创新药申报医保目录 国家医保局介绍2026年国家医保药品目录及商业健康保险创新药品目录调整工作安排,包括首次允许纳入2025年商保创新药目录的药品申报国家医保目录,新增“预申报”环节等。 国家医保局医药服务管理司司长黄心宇介绍,这是该局成立以来连续第9年动态调整医保目录,工作程序总体保持稳定,分为准备、申报、评审、谈判、公布结果5个阶段。预计...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.